Candel Therapeutics
CADL
CADL
21 hedge funds and large institutions have $7.44M invested in Candel Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
23% less capital invested
Capital invested by funds: $9.7M → $7.44M (-$2.26M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$143K | |
| 2 | +$64.6K | |
| 3 | +$34.3K | |
| 4 |
Renaissance Technologies
New York
|
+$28K |
| 5 |
BlackRock
New York
|
+$10.1K |
Top Sellers
| 1 | -$170K | |
| 2 | -$24K | |
| 3 | -$20.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$873 |